By MICHAEL MILLENSON Shared decision-making between doctors and patients may be “the pinnacle of patient-centered care,” but three new medical journal articles suggest it’s encountering more problems than peaks. Yet counterintuitively, it may be artificial intelligence that rescues this intimately human interaction. “Shared decision-making is at a crossroads,” declares a Perspective in the Journal of General…
Technology that offers tools that conform, de-identify, link and aggregate data and data science tools like AI, machine learning and advanced analytics, can help those researching rare diseases overcome the hurdles they face in discovery and development. The post Data Technology + RWD Are Positive for Rare Disease Treatment appeared first on MedCity News.
That is my recent paper with co-authors Shanshan Wang, Jason Shafrin, and Kirk Kerr in BMJ Open. The abstract is below: Objective To estimate the health economic value of postdischarge oral nutrition supplement (ONS) consumption among elderly adults who were malnourished during hospitalisation. Design A cost-effectiveness model was developed from a US payer perspective based on a…
Last month, the American Heart Association (AHA) and American College of Cardiology (ACA) put out a statement on how new cardiovascular medical technologies should be evaluated from a cost and value standpoint (Kazi et al. 2025). This is an update from their 2014 cost/value methodology (Anderson et al. 2014). What does the AHA/ACC statement say?…
The Trump administration is using migrant children held by the Department of Health and Human Services’ Office of Refugee Resettlement to lure parents and relatives into immigration detention, whether or not they have a criminal record. In one example, a dad went to an Immigration and Customs Enforcement office in New Mexico, thinking he was…
TURLOCK, Calif. — California, like much of the nation, is not producing enough nurses working at bedsides to meet the needs of an aging and diverse population, fueling a workforce crunch that risks endangering quality patient care. Nearly 60% of California counties, stretching between the borders with Mexico and Oregon, face a nursing shortage, according…
Randy Bolyga, founder CEO of RXNT, built his medical software company without venture capital, relying instead on SBA loans and a conservative, cash-positive growth strategy. He believes many venture capital-backed healthcare startups fail because they chase rapid growth without sustainable business models or a deep understanding of the market. The post Why One Healthcare Founder…
Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021. Despite the partial government shutdown, there are paths biotechs can pursue to the public markets. The post The 4 Biotech Companies on Track to IPO this Week Despite the Government Shutdown…
Iambic’s latest financing follows the presentation of data for its breast cancer drug during the recent European Society of Medical Oncology conference. Our financing roundup includes capital raised by startups developing novel therapies immunology, metabolic disorders, genetic diseases, and more. The post Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs appeared first…
As hundreds of rural hospitals face the risk of closure, healthcare leaders warn that the fallout extends far beyond patient outcomes. During a panel at ViVE in Los Angeles, healthcare leaders outlined how access to care underpins the economic stability of rural America. The post The Rural Care Crisis Is an Economic Issue, Not Just…